首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1618439

避孕產品市場規模：按產品、按年齡層、按性別、按分銷管道、按地區、範圍和預測

Contraceptives Market Size By Product (Drugs, Devices), By Age Group (Age 15-24, Age 25-34, Age 35-44, Above 44), By Gender (Male, Female), By Distribution Channel (Institutional Sales, Retail Sales, Online Sales), By Geographic Scope And Forecast

出版日期: 2024年09月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

避孕用品市場規模及預測

2023年避孕產品市場規模為200.7億美元，預估2024年至2031年複合年增長率為5.81%，2031年達315.4億美元。避孕產品，俗稱避孕方法，是用來預防懷孕的各種藥物或行為介入。避孕產品的主要目的是抑製或控制生殖過程，使個人或夫婦能夠根據自己的意願規劃和安排懷孕。這些干預措施可以採取多種形式，包括口服藥或注射劑等荷爾蒙避孕藥、子宮內避孕器 (IUD)、保險套等屏障方法以及生育意識實踐。

除了防止意外懷孕外，避孕產品還可以幫助您控制生育時間和間隔，從而幫助計劃生育。

此外，避孕藥也可用於治療某些健康問題，例如調節月經和治療多囊性卵巢症候群（PCOS）。

避孕產品市場動態

影響避孕產品市場的主要市場動態是：

主要市場推動因素

計劃生育意識不斷增強：

近年來，社會對生殖健康（性健康和生殖健康）的認識發生了顯著變化，並強調對計劃生育做出明智的決定。教育活動、醫療保健舉措以及透過眾多媒體管道大規模傳播訊息正在推動人們的認識不斷提高。因此，推動避孕產品市場的關鍵因素之一是對計劃生育意識的增強。

政府的避孕方法：

認識到控制人口成長的社會和經濟效益，一些政府推出了全面的計劃生育計劃。這些計劃往往包括補貼或免費分發避孕藥、教育活動以及改善醫療保健基礎設施等活動。因此，政府避孕措施是避孕產品市場的主要驅動力。

擴大男性對避孕藥具的接受度：

對避孕套和脈管系統等男性避孕用品的接受表明了向共同計劃生育的積極文化轉變。男性積極參與避孕決策不僅為夫婦提供了更多選擇，也培養了對生殖決策的平等意識。這種觀點的變化透過增加使用者數量和擴大所提供的避孕方法的範圍，對整體市場的成長是正面的。

主要課題

副作用：

某些避孕方法，尤其是荷爾蒙方法，如口服避孕藥和注射劑，可能會導致噁心、體重增加和情緒問題。因此，儘管避孕有多種好處，但市場成長的主要障礙之一是對其使用相關的潛在副作用和健康影響的擔憂。

文化/宗教對立：

一些文化和宗教對生殖健康和計劃生育持保守觀點，並認為避孕違反道德或宗教戒律。這種反對的形式可能是限制獲取資訊、限制取得避孕藥具或使用社會壓力。因此，文化和宗教態度仍然是某些國家和群體普遍接受避孕的重要障礙。

與避孕相關的社會恥辱：

誤解、文化禁忌和社會判斷都可能導致在獲得或使用避孕藥具時感到羞恥和尷尬。這種恥辱阻礙了人們自由討論和使用避孕方法，並阻礙了計劃生育的成功。

主要趨勢：

長效可逆避孕產品 (LARC) 的需求增加：

LARC，包括子宮內避孕器 (IUD) 和植入式避孕器，透過單次介入即可提供長期避孕效果，使其成為日常或常規避孕方法的便捷有效替代方案。LARC 因其高有效率、長期穩定性和低使用者依賴性而具有吸引力，使其成為那些尋求可靠、低維護避孕方法的人的理想選擇。這一趨勢正在增加避孕市場對 LARC 的需求。

男性避孕方法的增加：

男性避孕方法，包括正在開發的保險套、脈管系統和荷爾蒙避孕產品，提供了更廣泛的選擇。這種趨勢不僅促進了生育決策的平等參與，而且為夫婦提供了更廣泛的選擇，並根據個人喜好和需求量身定制計劃生育策略。

避孕用品市場區域分析

避孕產品市場更詳細的區域分析

北美：

根據驗證市場研究，預計北美在預測期內將主導避孕產品市場。該地區交通便利且完善的監管框架支持多種避孕產品的供應。這個成熟的市場為客戶提供了多種選擇，體現了該地區對生殖健康和計劃生育的奉獻精神。

高認知度和廣泛可用性也是北美的驅動力。此外，該地區的現代醫療保健系統確保了避孕藥具的廣泛使用，各行各業的人們都可以輕鬆獲得避孕藥具。

此外，該地區在生殖健康解決方案中採用和融入最新技術方面處於領先地位。在北美，智慧型手機生育追蹤應用程式、智慧避孕設備和荷爾蒙避孕方法的進步等創新已被廣泛接受，促進了動態和進步的市場環境。

歐洲：

歐洲避孕產品市場的特徵是傳統方法和新方法的平衡結合。該地區對性健康和生殖健康的重視體現在隨時可用的醫療服務和公眾宣傳工作上。歐洲廣泛的文化背景創造了多元化的市場，支持廣泛的品味和計劃生育選擇。

提高大眾對性傳染感染和其他健康問題的認識是推動歐洲採用避孕藥具的主要因素之一。人們越來越意識到生殖健康與整體健康之間的聯繫，並積極尋找和使用可靠的避孕藥具。這種注重健康的方法促進了對各種避孕選擇的持續需求，包括荷爾蒙和屏障方法。

此外，歐洲推遲生育的趨勢日益明顯，越來越多的人選擇在晚年建立家庭。隨著人們尋求有效的方法來計劃和間隔懷孕，社會規範的這些變化促使避孕需求的增加。歐洲市場的因應措施是為面臨母親發育遲緩這一複雜問題的人們提供各種解決方案。

亞太地區：

由於人口成長、意識提高和醫療基礎設施改善，亞太地區已成為一個充滿活力且快速擴張的避孕產品市場。該地區不同的文化背景影響著各種避孕方法的採用，為市場競爭者創造了機會和課題。

印度和中國等國家的出生率很高，人們對計劃生育的興趣增加，對有效避孕的需求也增加。政府措施和宣傳活動積極促進避孕措施的使用，將其作為控制該地區人口增長的負責任方式。

此外，教育活動對於提高亞太地區的避孕意識也很重要。大眾對避孕產品的認識和接受度不斷提高，是政府、非政府組織和衛生保健專業人員加大努力教育大眾瞭解該地區計劃生育選擇的結果。

Contraceptives Market size was valued at USD 20.07 Billion in 2023 and is projected to reach USD 31.54 Billion by 2031, growing at a CAGR of 5.81% from 2024 to 2031. Contraceptives, commonly known as birth control methods, are a variety of pharmacological or behavioral interventions used to prevent pregnancy. Contraceptives are primarily designed to inhibit or control the reproductive process, allowing individuals or couples to plan and schedule their pregnancies according to their desires. These interventions can include several forms, including hormonal contraceptives like oral tablets and injectables, intrauterine devices (IUDs), barrier methods like condoms, and fertility awareness practices.

Contraceptives are useful for more than just preventing unwanted pregnancies; they also aid in family planning by allowing individuals to control the timing and spacing of childbirth.

Moreover, contraceptives can be used to treat certain health issues, such as regulating menstrual periods and treating polycystic ovarian syndrome (PCOS).

Contraceptives Market Dynamics

The key market dynamics that are shaping the Contraceptives Market include:

Key Market Drivers

Increasing Awareness of Family Planning:

In recent years, there has been a significant shift in social attitudes regarding reproductive health, with an increased emphasis on making educated family planning decisions. The increase in awareness is being driven by educational campaigns, healthcare initiatives, and the mass diffusion of information via numerous media platforms. As a result, one of the key drivers fueling the contraceptive market is growing awareness of family planning.

Government Initiatives for Birth Control:

Recognizing the societal and economic benefits of controlled population increase, several governments are introducing comprehensive family planning programs. These programs tend to involve activities such as subsidized or free contraception distribution, educational campaigns, and healthcare infrastructure improvement. Thus, government birth control measures are a big driver of the Contraceptives Market.

Growing Acceptance of Contraceptives among Men:

The acceptability of male contraceptives such as condoms and vasectomy demonstrates a good cultural change toward shared family planning. Men who actively participate in contraceptive decisions not only provide couples with more options but also develop a sense of equality in reproductive decision-making. This changing perspective adds to overall market growth by increasing the number of users and broadening the contraceptive methods offered.

Key Challenges:

Side Effects:

Certain contraceptive methods, particularly hormonal ones such as oral contraceptives or injectables, might cause nausea, weight gain, or mood problems. As a result, despite the various benefits of contraception, one key barrier to market growth is anxiety about potential side effects and health consequences connected with their use.

Cultural and Religious Opposition:

Some cultures and religions hold conservative views on reproductive health and family planning, seeing contraception as contradictory to moral or religious precepts. This opposition takes the shape of limited information access, restricted contraceptive availability, or even societal pressure against its usage. Thus, cultural and religious attitudes continue to be important barriers to universal acceptance of contraception in certain countries and populations.

Social Stigma Associated with Contraceptives:

Misconceptions, cultural taboos, and societal judgments all lead to feelings of shame or embarrassment when obtaining or using contraception. This stigma discourages people from freely discussing or using contraceptive choices, which hinders successful family planning.

Key Trends:

Increasing Demand for Long-Acting Reversible Contraceptives (LARCs):

LARCs, which include intrauterine devices (IUDs) and contraceptive implants, provide long-term protection with a single intervention, making them a convenient and effective alternative to daily or regular contraception techniques. LARCs are appealing because of their high efficacy rates, long-term stability, and minimal user-dependent factors, making them ideal for people looking for dependable and low-maintenance birth control options. This trend results rise in demand for LARCs in the contraceptive market.

Rise in Male Contraception Methods:

Male contraceptives, including condoms, vasectomy, and developing hormonal contraceptives, provide a broader choice of possibilities. This trend not only promotes equal participation in reproductive decision-making but also offers couples a wider range of options, personalizing family planning tactics to their specific preferences and needs.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Contraceptives Market Regional Analysis

Here is a more detailed regional analysis of the Contraceptives Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Contraceptives Market during the forecast period. The high level of accessibility and a well-established regulatory framework in the region supports the availability of a diverse range of contraceptive products. This mature market provides customers with a variety of options, demonstrating the region's dedication to reproductive health and family planning.

The prevalence of high awareness and accessibility is another driving force in North America. Moreover, the region's modern healthcare system guarantees widespread access to contraceptive products, making it simple for people from all walks of life to obtain them.

Furthermore, the region is at the forefront of adopting and incorporating modern technology into reproductive health solutions. In North America, innovations like as smartphone fertility tracking apps, smart contraceptive devices, and advances in hormonal contraceptive methods are widely accepted, contributing to a dynamic and progressive market environment.

Europe:

Europe has a well-established Contraceptives Market that is characterized by a balanced mix of conventional and new methods. The region's emphasis on sexual and reproductive health is apparent in readily available healthcare services and popular awareness initiatives. Europe's broad cultural backdrop contributes to a diverse market, supporting a wide range of preferences and family planning options.

The population's growing awareness about sexually transmitted diseases and other health issues is one of the main factors bolstering the application of contraceptives in Europe. Individuals are becoming more aware of the link between reproductive health and general well-being, prompting them to actively seek out and use dependable contraceptives. This health-conscious approach contributes to a consistent demand for a variety of contraception choices, including hormonal and barrier methods.

Furthermore, Europe is witnessing an increasing trend of delayed motherhood, with people choosing to start families later in life. This shift in societal standards contributes to a rise in demand for contraception, as people seek efficient ways to plan and space their pregnancies. The European market responds by providing a variety of solutions for individuals navigating the complications of delayed motherhood.

Asia Pacific:

Asia Pacific emerges as a vibrant and fast-expanding Contraceptives Market, driven by a mix of population growth, increased awareness, and improved healthcare infrastructure. The region's diverse cultural landscape influences the adoption of various contraceptive methods, giving both possibilities and problems for market competitors.

High birth rates in countries like India and China have heightened the focus on family planning, driving up demand for effective contraception. Government initiatives and awareness campaigns actively promote the use of contraception as a responsible way to regulate population increase in this region.

Furthermore, educational campaigns are important in raising awareness about contraception in Asia Pacific. Growing public awareness and acceptance of contraceptives is a result of increased efforts by governments, non-governmental organizations, and healthcare practitioners to educate the public about family planning alternatives in this region.

Contraceptives Market: Segmentation Analysis

The Contraceptives Market is segmented based on Product, Age Group, Gender, Distribution Channel, And Geography.

Contraceptives Market, By Product

Drugs
Oral Contraceptive Pills
Injectable Contraceptives
Topical Contraceptives
Devices
Condoms
Diaphragms
Contraceptive Sponges
Vaginal Rings
Cervical Cap
Subdermal Implants
Intra-uterine Devices

Based on Product, the market is segmented into Drugs and Devices. The hot-melt segment is estimated to dominate the Contraceptives Market. The devices segment dominates the Contraceptives Market. Devices, such as intrauterine devices (IUDs) and contraceptive implants, have gained popularity due to their significant benefits over traditional techniques. These devices provide a long-term and hassle-free alternative to birth control, meeting the modern lifestyle needs for simplicity and dependability. The effectiveness of devices in preventing unplanned pregnancies, combined with their low maintenance requirements, has contributed to their growing popularity among users wanting longer periods of protection without daily involvement. Moreover, advances in device technology, such as the creation of hormonal-releasing IUDs, improve their efficacy and customer satisfaction.

Contraceptives Market, By Age Group

Age 15-24
Age 25-34
Age 35-44
Above 44

Based on Age Group, the market is segmented into Age 15-24, Age 25-34, Age 35-44, and above 44. The 25-34 age group is estimated to dominate the Contraceptives Market during the forecast period. This age group reflects a life stage marked by higher education, career advancement, and the building of stable partnerships. Individuals in this age group are frequently more active in family planning, looking for dependable contraceptive methods that correspond with their life objectives and aspirations. The desire for control over reproductive choices, along with a greater understanding of the significance of responsible family planning, promotes the demand for contraception among people aged 25 to 34.

Contraceptives Market, By Gender

Male
Female

Based on Gender, the market is segmented into Male and Female. The female segment is estimated to dominate the Contraceptives Market during the forecast period. Women have traditionally been the key decision-makers and users of contraceptive techniques, which include a wide range of alternatives from hormonal contraceptives such as oral tablets and injectables to intrauterine devices (IUDs) and barrier methods like condoms. The prevalence of female-centric contraceptive techniques is consistent with biological and societal considerations, as women bear the physical cost of pregnancy and childbirth. Moreover, the evolution of societal norms, in which women are increasingly taking an active role in reproductive health decisions, strengthens their position in the contraceptive industry.

Based on Distribution Channel, the market is segmented into Institutional Sales, Retail Sales, and Online Sales. The retail sales segment is estimated to dominate the market over the forecast period. Retail sales channels, such as pharmacies, supermarkets, and convenience stores, account for a significant share due to their extensive accessibility and convenience for people looking for contraceptives. These stores offer a discrete and easily accessible setting for people to buy contraception, encouraging a sense of privacy and comfort. In addition, having a varied range of contraceptive options on retail shelves allows consumers to make informed decisions based on their tastes and individual needs. The retail distribution channel not only meets immediate consumer needs, but also serves as an important educational platform, with knowledgeable employees providing advice and information.

Key Players

The "Contraceptives Market" study report will provide valuable insight emphasizing the global market. The major players in the market are
Pfizer, Bayer AG, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc., Shionogi & Co. Ltd., Hisamitsu Pharmaceutical Co. Inc., HIKMA Pharmaceuticals PLC, Lupin Limited, Mankind Pharma Ltd., Glenmark Pharmaceuticals Ltd., Cipla Limited, Abbott Laboratories, Organon & Co., Besins Healthcare Pvt. Ltd., Famy Care Ltd., and DKT International.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In January 2024, Evotec, a medicinal discovery and development business, announced a collaboration with Bayer to create a non-hormonal oral male contraception. This announcement marks a significant advancement in the ongoing hunt for novel and effective male contraceptive methods.
In January 2024, Teva received FDA approval for Phexxi(R), a non-hormonal vaginal contraception gel. This new method gives women another way to avoid conception without taking hormones.
In December 2023, Organon announced positive Phase 3 clinical trial findings for AM001, a new long-acting injectable contraception. This new approach could provide women with an easy and efficient form of contraception for up to six months.
In November 2023, The Bill & Melinda Gates Foundation announced a $8.3 million grant to research a three-month-long-acting contraceptive patch. This new alternative may be especially valuable in areas with limited access to healthcare.

1. INTRODUCTION OF GLOBAL CONTRACEPTIVES MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL CONTRACEPTIVES MARKET OUTLOOK

4.1. Overview
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis

5. GLOBAL CONTRACEPTIVES MARKET, BY PRODUCT

5.1. Overview
5.2. Drugs
- 5.2.1. Oral Contraceptive Pills
- 5.2.2. Injectable Contraceptives
- 5.2.3. Topical Contraceptives
5.3. Devices
- 5.3.1. Condoms
- 5.3.2. Diaphragms
- 5.3.3. Contraceptive Sponges
- 5.3.4. Vaginal Rings
- 5.3.5. Cervical Cap
- 5.3.6. Subdermal Implants
- 5.3.7. Intra-uterine Devices

6. GLOBAL CONTRACEPTIVES MARKET, BY AGE GROUP

6.1. Overview
6.2. Age 15-24
6.3. Age 25-34
6.4. Age 35-44
6.5. Above 44

7. GLOBAL CONTRACEPTIVES MARKET, BY GENDER

7.1. Overview
7.2. Male
7.3. Female

8. GLOBAL CONTRACEPTIVES MARKET, BY GEOGRAPHY

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. Europe
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Rest of Europe
8.4. Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9. GLOBAL CONTRACEPTIVES MARKET COMPETITIVE LANDSCAPE

9.1. Overview
9.2. Company Market Ranking
9.3. Key Development Strategies

10. COMPANY PROFILES

10.1. Pfizer
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2. Bayer AG
- 10.2.1. Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Outlook
- 10.2.4. Key Developments
10.3. Johnson & Johnson
- 10.3.1. Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Outlook
- 10.3.4. Key Developments
10.4. Teva Pharmaceutical Industries Ltd.
- 10.4.1. Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Outlook
- 10.4.4. Key Developments
10.5. Novartis AG
- 10.5.1. Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Outlook
- 10.5.4. Key Developments
10.6. Merck & Co. Inc.
- 10.6.1. Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Outlook
- 10.6.4. Key Developments
10.7. Shionogi & Co. Ltd
- 10.7.1. Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Outlook
- 10.7.4. Key Developments
10.8. Hisamitsu Pharmaceutical Co. Inc.
- 10.8.1. Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Outlook
- 10.8.4. Key Developments
10.9. HIKMA Pharmaceuticals PLC
- 10.9.1. Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Outlook
- 10.9.4. Key Developments
10.10. Lupin Limited
- 10.10.1. Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Outlook
- 10.10.4. Key Developments